Genmab — Marts 2020

[Solsen]

Det er vel også her Genmab får højst royalty af JNJ aftalen på duobodies.

[Legolas23]

Et fase 3-forsøg med kombinationsbehandling med lægemidlet Ninlaro har ikke vist statisk signifikant forbedring hos patienter med nydiagnosticeret knoglemarvskræft.

[Legolas23]

https://m.medwatch.dk/article/11999340

[E_L]

great news bibob!!

[E_L]

i did not know 08:14? that is extra good news then

[bibob]

Yes E L. Just what we where wating for.

[E_L]

i couldnt read the fiercebiotech, this is the JNJ press release
https://www.jnj.com/janssen-announces-u-s-fda-breakthrough-therapy-designation-granted-for-jnj-6372-for-the-treatment-of-non-small-cell-lung-cancer

[JKY_VH]

Super bibob og god dag til alle:-)

[E_L]

it may take some time for the press to understand that this product is related to Genmab...

[bibob]

Yes. They are only hurry when its' bad news.

[JKY_VH]

Til gengæld er vi tilbage til den situation at vi falder på gode nyheder:-(

[GeorgeBest]

Nordea wrote that it is positive news, but why doesn't Genmab send out a press release?

[Peter_Panik]

1400

[Peter_Panik]

Har købt dem tilbage, som jeg smed på 1700 niveauet.

[JKY_VH]

1402,50 iflg Nordnet, men godt gjort alligevel.

[E_L]

@Legolas , so that is a second drop-out, after Empliciti earlier this week

[bibob]

E L. And yes. two competitors out. ( knock out )

[Legolas23]

Jeps, two out

[nohope]

• but how many still in progress - out there...

[bibob]

Yes. But maybe two of the tuffest.